A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Memorial Sloan Kettering Cancer Center · NCT06312124
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45+ · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 266
- US sites recruiting
- 9
- Study start
- March 8, 2024
- Record last updated
- June 24, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to find out how many participants are interested in a surgical preventive procedure after watching an educational video. Before and after watching the video, participants will complete questionnaires in the clinic.
Being studied: Educational Module; Salpingectomy
Conditions: Surgery
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Part I
- Age ≥45 years
- Scheduled visit with a nongynecologic surgeon
- Female or assigned female at birth
Part II
- Age ≥45 years
- At least one in situ fallopian tube
- No desire or plan to have children in the future
- Average risk of developing ovarian cancer
° Note: Average risk patients are defined as patients with no known genetic risk factor for developing ovarian cancer. Patients who, after obtaining family history, are suspected to have a hereditary ovarian cancer syndrome but have not yet been tested, will be referred for genetic evaluation.
- Planned nongynecologic, intraabdominal, or pelvic surgery
- Deemed to be a suitable candidate by gynecologic surgeon and primary nongynecologic surgeon (for example, on the basis of surgical history and current malignancy status)
- Approved and signed informed consent
Exclusion Criteria
Part I
- Not fluent in English or Spanish
° If there is a non-english or non-spanish speaking participant who is a strong candidate and meets all other criteria for Part 2, they are able to go directly onto Part 2 without completing Part 1. (Please see additional details in section 4.1 and 7.0.)
- Known inherited ovarian cancer susceptibility
Part II
- Personal history of a gynecologic malignancy
- Carrier of a hereditary breast or ovarian cancer variant (e.g., BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, MLH1, MSH2, MSH6, PMS2)
- Suspicious ovarian, fallopian tube, or uterine lesion on preoperative imaging
- Previous bilateral salpingectomy or bilateral salpingo-oophorectomy
- Presence of ESSURE, or other tubal-implanted birth control at the time of surgery
- Current pregnancy
- Emergent procedure or emergency procedure that has to be completed within 24 hours where clinical consent occurs in the inpatient setting or where the patient's immediate well-being is in danger or condition may be life threatening
- Primary surgeon anticipates that OS will add significant time (>30-40min) to the planned procedure.
- Inability to access the pelvis (ex., patient prone/lateral position) during the planned procedure.
- Known history of pelvic fibrosis or significant adhesions.
- Procedures with palliative intent only
Recruiting US locations
Johns Hopkins University (Data Collection Only)
Baltimore, MD 21287
Site contact: Rebecca Stone, MD · 410-955-8240
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, NJ 07920
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, NJ 07748
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, NJ 07645
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)
Commack, NY 11725
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, NY 10604
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, NY 10065
Site contact: Kara Long Roche, MD · 646-608-3787
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, NY 11553
Site contact: Kara Long Roche, MD · 646-608-3787
MD Anderson Cancer Center (Data Collection Only)
Houston, TX 77030
Site contact: Larissa Meyer, MD · 713-792-6161
Study contacts (from the official record)
- Kara Long Roche, MD · 212-639-7043 · longrock@mskcc.org
- Martin Weiser, MD · 212-639-6698 · weiser1@mskcc.org
Similar studies in Maryland
All healthy volunteers studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 21–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Study of Intravenous ZMA001 in Healthy Subjects
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Bethesda, MD
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Johns Hopkins University
- Location
- Baltimore, MD
- Eligibility basics
- Ages 21–55